Inside IES Research

Notes from NCER & NCSER

Building Evidence: Changes to the IES Goal Structure for FY 2019

The IES Goal Structure was created to support a continuum of education research that divides the research process into stages for both theoretical and practical purposes. Individually, the five goals – Exploration (Goal 1), Development and Innovation (Goal 2), Efficacy and Replication (Goal 3), Effectiveness (Goal 4), and Measurement (Goal 5) – were intended to help focus the work of researchers, while collectively they were intended to cover the range of activities needed to build evidence-based solutions to the most pressing education problems in our nation. Implicit in the goal structure is the idea that over time, researchers will identify possible strategies to improve student outcomes (Goal 1), develop and pilot-test interventions (Goal 2), and evaluate the effects of interventions with increasing rigor (Goals 3 and 4).

Over the years, IES has received many applications and funded a large number of projects under Goals 1-3.  In contrast, IES has received relatively few applications and awarded only a small number of grants under Goal 4. To find out why – and to see if there were steps IES could take to move more intervention studies through the evaluation pipeline – IES hosted a Technical Working Group (TWG) meeting in 2016 to hear views from experts on what should come after an efficacy study (see the relevant summary and blog post). IES also issued a request for public comment on this question in July 2017 (see summary).

The feedback we received was wide-ranging, but there was general agreement that IES could do more to encourage high-quality replications of interventions that show prior evidence of efficacy. One recommendation was to place more emphasis on understanding “what works for whom” under various conditions.  Another comment was that IES could provide support for a continuum of replication studies.  In particular, some commenters felt that the requirements in Goal 4 to use an independent evaluator and to carry out an evaluation under routine conditions may not be practical or feasible in all cases, and may discourage some researchers from going beyond Goal 3.   

In response to this feedback, IES revised its FY 2019 RFAs for Education Research Grants (84.305A) and Special Education Research Grants (84.324A) to make clear its interest in building more and better evidence on the efficacy and effectiveness of interventions. Among the major changes are the following:

  • Starting in FY 2019, Goal 3 will continue to support initial efficacy evaluations of interventions that have not been rigorously tested before, in addition to follow-up and retrospective studies.
  • Goal 4 will now support all replication studies of interventions that show prior evidence of efficacy, including but not limited to effectiveness studies.
  • The maximum amount of funding that may be requested under Goal 4 is higher to support more in-depth work on implementation and analysis of factors that moderate or mediate program effects.

The table below summarizes the major changes. We strongly encourage potential applicants to carefully read the RFAs (Education Research, 84.305A and Special Education Research, 84.324A) for more details and guidance, and to contact the relevant program officers with questions (contact information is in the RFA).

Applications are due August 23, 2018 by 4:30:00 pm Washington DC time.


Name Change

Focus Change

Requirements Change

Award Amount Change

Goal 3

Formerly “Efficacy and Replication;” in FY2019, “Efficacy and Follow-Up.”

Will continue to support initial efficacy evaluations of interventions in addition to follow-up and retrospective studies.

No new requirements.

No change.

Goal 4

Formerly “Effectiveness;” in FY2019, “Replication: Efficacy and Effectiveness.”

Will now support all replications evaluating the impact of an intervention. Will also support Efficacy Replication studies and Re-analysis studies.

Now contains a requirement to describe plans to conduct analyses related to implementation and analysis of key moderators and/or mediators. (These were previously recommended.)

Efficacy Replication studies maximum amount: $3,600,000.

Effectiveness studies maximum amount: $4,000,000.

Re-analysis studies maximum amount: $700,000.



By Thomas Brock (NCER Commissioner) and Joan McLaughlin (NCSER Commissioner)